TYRA BIOSCIENCES
Live / Allowed — Third extension granted (statement of use) (as of 18 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98529313
- Mark type
- Word mark
- Filed
- 01 May 2024
- Published for opposition
- 31 Dec 2024
- Attorney of record
- Kevin M. Bovard
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for the treatment of rare genetic diseases; pharmaceuticals for the treatment of musculo-skeletal disorders; pharmaceuticals for the treatment of skeletal dysplasia; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of cells that are resistant to drugs; pharmaceuticals for the treatment and prevention of drug resistance; anti-cancer pharmaceuticals
- Class 042 — Scientific and technological services: Research and development of drugs in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research for medical purposes in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; clinical research in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research and development of pharmaceuticals for the treatment of cancer, rare diseases, musculo-skeletal disorders, and skeletal dysplasia.
- Class 044 — Medical, beauty and agricultural services: providing medical information; providing medical information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; Providing a web site featuring medical information; Providing a website featuring information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; providing information in the field of pharmaceuticals; providing medical information in the field of oncology; providing a website featuring information in the field of the diagnosis and treatment of cancer.
Owner
- Tyra Biosciences, Inc., Carlsbad, CA, US
- Tyra Biosciences, Inc., Carlsbad, CA, US
Prior registrations
Prosecution history
- 19 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2026 — SOU EXTENSION 3 GRANTED
- 18 Aug 2026 — SOU EXTENSION 3 FILED
- 18 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2026 — SOU EXTENSION 2 GRANTED
- 12 Feb 2026 — SOU EXTENSION 2 FILED
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2025 — SOU EXTENSION 1 GRANTED
- 11 Aug 2025 — SOU EXTENSION 1 FILED
- 11 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION